Advertising

Marchmont Capital Partners presents bi-lingual daily news website for Russian and foreign business communities devoted to innovation economy, modernization and investment news from Russia`s regions. Our website is visited daily by more than 8000, monthly by more than 200 000 people from as many as 219 countries all over the world.

www.marchmontnews.com today:

  • Key news on regional finances, investments and innovation in Russian and English language daily;
  • Analytical researches and feature stories;
  • In the focus: perspective start-ups and seed technology companies;
  • Exclusive expert opinions on economics, videos and blogs from the leading Russian and international experts;
  • International innovation news;
  • Searching opportunities: geography, economic sectors, name of the company, people, date of publication etc.;
  • News archive more than 16 500 articles;
  • Online access to Marchmont Investment Guide journal;
  • Customizable RSS-feed to your site or RSS reader.

Download. Webstats.

Download. Webaudience

Why advertise at www.marchmontnews.com?

  • To promote your company`s image in Russia and abroad;
  • To get access and bring your message exactly to your target audience;
  • To increase your company`s brand name recognition among your target audiences;
  • To get a high percent of response to advertisements with effective advertising costs

Download. Price list for web advertising

 

Feature stories

27 Mar '15
18 Mar '15
Russian innovation companies step up their efforts in...
10 Mar '15
The manner with which Russian ideas are presented and...
Search (News archive - 18919)
Technology Commercialization
Advertising
Hi-tech Technopark Association of Russia

Latest News

30 Mar '15
Russian developers are said to have created a smart...
30 Mar '15
Russian wedding start-up Wedvice has received $400k...
27 Mar '15

Most read stories from last week

30 Mar '15
Russian wedding start-up Wedvice has received $400k...
30 Mar '15
Russian developers are said to have created a smart...
31 Mar '15
Next gen blood-based drug production is slated for...